Literature DB >> 27807371

Cancer: Therapy for colorectal cancer liver metastases: understanding resistance.

Katrina Ray.   

Abstract

Entities:  

Year:  2016        PMID: 27807371     DOI: 10.1038/nrgastro.2016.183

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  2 in total

1.  Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases.

Authors:  Nuh N Rahbari; Dmitriy Kedrin; Joao Incio; Hao Liu; William W Ho; Hadi T Nia; Christina M Edrich; Keehoon Jung; Julien Daubriac; Ivy Chen; Takahiro Heishi; John D Martin; Yuhui Huang; Nir Maimon; Christoph Reissfelder; Jurgen Weitz; Yves Boucher; Jeffrey W Clark; Alan J Grodzinsky; Dan G Duda; Rakesh K Jain; Dai Fukumura
Journal:  Sci Transl Med       Date:  2016-10-12       Impact factor: 17.956

2.  Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.

Authors:  Sophia Frentzas; Eve Simoneau; Victoria L Bridgeman; Peter B Vermeulen; Shane Foo; Eleftherios Kostaras; Mark Nathan; Andrew Wotherspoon; Zu-Hua Gao; Yu Shi; Gert Van den Eynden; Frances Daley; Clare Peckitt; Xianming Tan; Ayat Salman; Anthoula Lazaris; Patrycja Gazinska; Tracy J Berg; Zak Eltahir; Laila Ritsma; Jacco Van Rheenen; Alla Khashper; Gina Brown; Hanna Nystrom; Malin Sund; Steven Van Laere; Evelyne Loyer; Luc Dirix; David Cunningham; Peter Metrakos; Andrew R Reynolds
Journal:  Nat Med       Date:  2016-10-17       Impact factor: 53.440

  2 in total
  1 in total

Review 1.  Perspective on the dynamics of cancer.

Authors:  Youcef Derbal
Journal:  Theor Biol Med Model       Date:  2017-10-03       Impact factor: 2.432

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.